Compare Core Scientific Inc (CORZ) vs Veritone Inc (VERI) Price & Performance

Core Scientific (CORZ) trades at $15.36, down 3.64% with bearish technical signals despite strong analyst support. The company shows significant financial challenges with a -324.9% net income margin and consecutive quarterly earnings misses, though revenue growth from $319M to $440M is projected. Recent executive appointments and insider buying signal internal confidence amid the company's pivot toward AI data center infrastructure.

The stock presents a high-risk opportunity with Wall Street maintaining bullish price targets averaging $32.75, representing 113% upside potential. However, substantial losses, negative cash flow, and competitive pressures in the AI infrastructure space create significant execution risk. Investors must weigh analyst optimism against fundamental weaknesses and market volatility.

VERI stock trades at $0.5851, down 15.36% in 24 hours, reflecting significant bearish technical momentum. The company reported a net loss of $111.73 million on $92.19 million revenue in 2025, with negative profitability margins. Recent news includes a $15 million equity offering and partnerships with ATP Media and ZeroEyes, but legal investigations and consistent earnings misses add uncertainty. Analyst consensus is mixed with a $3.75 price target, suggesting substantial potential upside from current levels if operational improvements materialize.

The outlook remains high-risk due to persistent losses and cash burn, offset by analyst optimism for long-term AI growth. Investment opportunity hinges on successful cost reduction and revenue acceleration from new partnerships. Key risks include ongoing legal scrutiny, competitive pressures, and the need for additional financing to sustain operations.